- |||||||||| Darzalex IV (daratumumab) / J&J
[VIRTUAL] A Case of Respiratory Failure in a Patient Receiving Multiple Immune-Modulatory Agents () - Mar 14, 2021 - Abstract #ATS2021ATS_2670; She was being treated for Multiple Myeloma with Atezolizumab and Daratumumab over the last 3 years and using chronic nitrofurantoin for recurrent UTIs over the last year...Treatment with trimethoprim-sulfamethoxazole and higher doses of steroids was initiated...Pneumocystis has long been associated with HIV and other immunosuppressed conditions; however, there have been increasing cases associated with immune-modulatory agents. Overall, our case illustrates the importance of a broad differential and the utility of diagnostic bronchoscopy and imaging to avoid misdiagnosis in a patient receiving immune-modulatory therapies who presents with respiratory failure.
- |||||||||| nitrofurantoin / Generic mfg.
Journal: Nitrofurantoin for urinary tract infections in men: it is possible (Pubmed Central) - Dec 19, 2020 However, this is undesirable because of side effects, more microbiome disturbance and resistance development. Therefore, nitrofurantoin is a valuable treatment option for a urinary tract infection in men, provided that systemic symptoms are absent.
- |||||||||| Nuzyra (omadacycline) / Paratek
Enrollment closed: Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis (clinicaltrials.gov) - May 10, 2019 P2, N=225, Active, not recruiting, N=40 --> 0 | Trial completion date: Jul 2019 --> Jul 2018 | Recruiting --> Withdrawn | Trial primary completion date: Jul 2019 --> Jul 2018 Recruiting --> Active, not recruiting
- |||||||||| Nuzyra (omadacycline) / Paratek
Trial completion date, Trial primary completion date: Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis (clinicaltrials.gov) - Apr 2, 2019 P2, N=200, Recruiting, Recruiting --> Active, not recruiting Trial completion date: Mar 2019 --> Jul 2019 | Trial primary completion date: Mar 2019 --> Jun 2019
- |||||||||| cephalexin / Generic mfg., nitrofurantoin / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Treatment of Asymptomatic Bacteriuria in Pregnancy (clinicaltrials.gov) - Apr 18, 2018 P=N/A, N=13, Terminated, Recruiting --> Completed N=101 --> 13 | Trial completion date: Mar 2019 --> Jan 2018 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Jan 2018; Inability to enroll patients at anticipated rate.
- |||||||||| Enrollment open: Preoperative Antibiotic PNL Study (clinicaltrials.gov) - Mar 22, 2016
P4, N=80, Enrolling by invitation, Not yet recruiting --> Recruiting | Initiation date: Apr 2016 --> Aug 2016 Active, not recruiting --> Enrolling by invitation
- |||||||||| nitrofurantoin / Generic mfg.
Enrollment change, Trial termination, Surgery: APPIC: Nitrofurantoin and Urinary Tract Infections (UTIs) (clinicaltrials.gov) - Jan 26, 2016 P=N/A, N=10, Terminated, Not yet recruiting --> Recruiting N=108 --> 10 | Recruiting --> Terminated; Inadequate patient recruitment
|